Florida Drug Treatment Center to Add Neurotransmitter Testing to Alcoholism Treatment

Share Article

After extensive experience with drug rehab clients, The Ambrosia Treatment Centers, located in both Singer Island and Port St. Lucie, on Florida's Southeast coast, have announced the availability of neurotransmitter testing for the treatment of Alcoholism. This cutting edge testing will help clients in their recovery from alcoholism in addition to its previous applications with general addiction treatment.

One of the most popular, and most effective, types of alcohol treatment is the dual diagnosis program. What this type of program does is treat both the alcoholism along with any co-occurring mental health disorders, such as depression or anxiety. The philosophy at the core of dual diagnosis centers is that addictions and mental health disorders are interconnected, and if one is treated while the other is ignored, than the untreated disorder is liable to run rampant and cause a relapse of the treated disorder. Most dual diagnosis centers run on a similar model, with the addictions being treated with one on one and group therapy, as well as educational groups and supplementary therapies. The mental health disorders are also treated with the talk therapies, but the main avenue that most centers use to treat them is the trial and error prescription of psychiatric medications. The Ambrosia Treatment Centers have now taken the guesswork out of the applications of these medications with the use of neurotransmitter testing for the treatment of alcoholism.

Neurotransmitters are chemicals that are naturally produced in the brain that are responsible for our moods. There are dozens of different chemicals that help regulate our nervous system, although not all neurotransmitters are equally important, with a handful, among them Serotonin, Dopamine and Glutamate being very significant in the way that the brain functions. Most psychiatrists and treatment centers try to make a best guess at where the patient's neurotransmitter levels stand based on answers to questionnaires or interviews, and then prescribe medications that alter the levels of those neurotransmitters. The psychiatrists then need to wait several weeks to hear the patient's reports about their mood on the medication before deciding the medication's effectiveness, changing doses, or changing medications completely. All they while, the psychiatrist must keep in mind that the alteration up or down in the patients mood may have as much to do with external events as the medication. The Ambrosia Treatment Center's use of neurotransmitter testing, however, makes assessing an incoming alcoholic's levels of these vital brain chemicals guesswork free.

The actual testing of a client's neurotransmitter levels is done using a non invasive urine test. The sample is tested to assess levels of the 12 most important neurotransmitters to mood. These include all of the chemicals that the most commonly prescribed psychiatric medications are used to modify. The results of the test are interpreted by a qualified psychiatrist, who is then able to prescribe medication as well as recommend cutting edge over the counter supplements to target exactly the transmitters that are deficient in the alcoholic, or, in appropriate cases, a broad spectrum solution that will help raise the levels of all appropriate transmitters.

This approach to psychiatric treatment of alcoholics represents a true breakthrough in treatment of dually diagnosed alcoholics. Instead of months of trial and error use of powerful psychiatric medications, some of which may produce negative effects, the recovering alcoholics given access to targeted medications and supplements based on the absolute levels of the chemicals that the medications are designed to alter, not based on a best guess of a doctor. The Ambrosia Treatment Centers have undergone a pilot program of the new testing before a full launch, and the results have been astounding. Not only are clients reporting the intended results of more effective treatment of their co-occurring disorders, but they are also reporting a better engagement in the therapeutic process. Clients have reported that they feel a greater participation in their care when they are able to sit down with a doctor and not just report how they feel, but actually sit with staff while they are explained exactly what the concrete testing results say about them, and how they are able to begin treatment. It is through this cutting edge, progressive treatment, and others like them that The Ambrosia Treatment Centers plan on continuing to lead the field in dual diagnosis treatment.

###

Share article on social media or email:

View article via:

Pdf Print